Literature DB >> 24947034

Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.

David D Rahn1, Meadow M Good, Shayzreen M Roshanravan, Haolin Shi, Joseph I Schaffer, Ravinder J Singh, R Ann Word.   

Abstract

CONTEXT: Pelvic organ prolapse (POP) increases in prevalence with age; recurrence after surgical repair is common.
OBJECTIVE: The objective of the study was to determine the effects of local estrogen treatment on connective tissue synthesis and breakdown in the vaginal wall of postmenopausal women planning surgical repair of POP.
DESIGN: This was a randomized trial.
SETTING: The study was conducted at an academic tertiary medical center. PATIENTS OR OTHER PARTICIPANTS: Postmenopausal women with a uterus and symptomatic anterior and/or apical prolapse at stage 2 or greater participated in the study. INTERVENTION: Estrogen (Premarin) or placebo cream for 6 weeks preoperatively was the intervention. MAIN OUTCOME MEASURES: Full-thickness anterior apical vaginal wall biopsies were obtained at the time of hysterectomy and analyzed for mucosa and muscularis thickness, connective tissue synthesis, and degradation. Serum levels of estrone and 17β-estradiol were analyzed at baseline and the day of surgery using highly sensitive liquid chromatography-tandem mass spectrometry.
RESULTS: Fifteen women per group (n = 30 total) were randomized; 13 per group underwent surgery. Among drug-adherent participants (n = 8 estrogen, n = 13 placebo), epithelial and muscularis thickness was increased 1.8- and 2.7-fold (P = .002 and P =.088, respectively) by estrogen. Collagen types 1α1 and 1α2 mRNA increased 6.0- and 1.8-fold in the vaginal muscularis (P < .05 for both); collagen type Ia protein increased 9-fold in the muscularis (P = .012), whereas collagen III was not changed significantly. MMP-12 (human macrophage elastase) mRNA was suppressed in the vaginal mucosa from estrogen-treated participants (P = .011), and matrix metalloprotease-9 activity was decreased 6-fold in the mucosa and 4-fold in the muscularis (P = .02). Consistent with menopausal norms, serum estrone and 17β-estradiol were low and did not differ among the two groups.
CONCLUSIONS: Vaginal estrogen application for 6 weeks preoperatively increased synthesis of mature collagen, decreased degradative enzyme activity, and increased thickness of the vaginal wall, suggesting this intervention improves both the substrate for suture placement at the time of surgical repair and maintenance of connective tissue integrity of the pelvic floor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24947034      PMCID: PMC4184065          DOI: 10.1210/jc.2014-1216

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Morphometric properties of the posterior vaginal wall in women with pelvic organ prolapse.

Authors:  Muriel K Boreham; Clifford Y Wai; Rodney T Miller; Joseph I Schaffer; R Ann Word
Journal:  Am J Obstet Gynecol       Date:  2002-12       Impact factor: 8.661

2.  Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma.

Authors:  P S Cooke; F D Uchima; D K Fujii; H A Bern; G R Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  The effects of estrogens on cytology and vascularization of the vaginal epithelium in climacteric women.

Authors:  B Bercovici; G Uretzki; Y Palti
Journal:  Am J Obstet Gynecol       Date:  1972-05-01       Impact factor: 8.661

4.  The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.

Authors:  J Manonai; U Theppisai; S Suthutvoravut; U Udomsubpayakul; A Chittacharoen
Journal:  J Obstet Gynaecol Res       Date:  2001-10       Impact factor: 1.730

5.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.

Authors:  Steven Swift; Patrick Woodman; Amy O'Boyle; Margie Kahn; Michael Valley; Deirdre Bland; Wei Wang; Joe Schaffer
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

6.  Prevalence and trends of symptomatic pelvic floor disorders in U.S. women.

Authors:  Jennifer M Wu; Camille P Vaughan; Patricia S Goode; David T Redden; Kathryn L Burgio; Holly E Richter; Alayne D Markland
Journal:  Obstet Gynecol       Date:  2014-01       Impact factor: 7.661

7.  Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma.

Authors:  Robert E Nelson; Stefan K Grebe; Dennis J OKane; Ravinder J Singh
Journal:  Clin Chem       Date:  2003-12-04       Impact factor: 8.327

8.  Regulation of elastolytic proteases in the mouse vagina during pregnancy, parturition, and puerperium.

Authors:  Cecilia K Wieslander; Spyridon I Marinis; Peter G Drewes; Patrick W Keller; Jesús F Acevedo; R Ann Word
Journal:  Biol Reprod       Date:  2007-11-14       Impact factor: 4.285

9.  Estrogen enhances cystatin C expression in the macaque vagina.

Authors:  Ov D Slayden; Kevin Hettrich; Rebecca S Carroll; Lesley N Otto; Amanda L Clark; Robert M Brenner
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

10.  Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.

Authors:  Gloria Bachmann; Céline Bouchard; Diana Hoppe; Radhika Ranganath; Corrado Altomare; Alberta Vieweg; Jay Graepel; Eileen Helzner
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

View more
  19 in total

Review 1.  Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines.

Authors:  David D Rahn; Renée M Ward; Tatiana V Sanses; Cassandra Carberry; Mamta M Mamik; Kate V Meriwether; Cedric K Olivera; Husam Abed; Ethan M Balk; Miles Murphy
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

2.  The role of tenascin-X in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse: an immunohistochemical study.

Authors:  Barbara Bodner-Adler; Klaus Bodner; Oliver Kimberger; Ksenia Halpern; Cora Schneidinger; Peter Haslinger; Christian Schneeberger; Reinhard Horvat; Wolfgang Umek
Journal:  Int Urogynecol J       Date:  2018-12-10       Impact factor: 2.894

3.  Oestrogen-soaked vaginal packing for decubitus ulcer in advanced pelvic organ prolapse: a case series.

Authors:  Bahiyah Abdullah; Su Yen Khong; Peng Chiong Tan
Journal:  Int Urogynecol J       Date:  2015-12-30       Impact factor: 2.894

4.  Effect of vaginal or systemic estrogen on dynamics of collagen assembly in the rat vaginal wall.

Authors:  T Ignacio Montoya; P Antonio Maldonado; Jesus F Acevedo; R Ann Word
Journal:  Biol Reprod       Date:  2014-12-23       Impact factor: 4.285

5.  Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract.

Authors:  P Antonio Maldonado; T Ignacio Montoya; Jesus F Acevedo; Patrick W Keller; R Ann Word
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

6.  Acacia Nilotica: New Plant for Help in Pelvic Organ Prolapse.

Authors:  Nasibeh Roozbeh; Leili Darvish
Journal:  J Menopausal Med       Date:  2016-12-31

7.  Vaginal cuff dehiscence and evisceration 11 years after a radical hysterectomy: A case report.

Authors:  Yacine Ben Safta; Montassar Ghalleb; Aymen Baccari; Ghassen Hamdi El Kebir; Sami Daldoul; Sofiene Sayari; Mounir Ben Moussa
Journal:  Int J Surg Case Rep       Date:  2017-10-28

8.  Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall.

Authors:  Christopher M Ripperda; Pedro Antonio Maldonado; Jesus F Acevedo; Patrick W Keller; Yucel Akgul; John M Shelton; Ruth Ann Word
Journal:  Menopause       Date:  2017-07       Impact factor: 2.953

9.  Design of a Randomized Clinical Trial of Perioperative Vaginal Estrogen Versus Placebo With Transvaginal Native Tissue Apical Prolapse Repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE).

Authors:  David D Rahn; Holly E Richter; Vivian W Sung; Wilma I Larsen; Linda S Hynan
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-01-01       Impact factor: 1.913

10.  Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.

Authors:  Adrian Gaspar; Hugo Brandi; Valentin Gomez; Daniel Luque
Journal:  Lasers Surg Med       Date:  2016-08-22       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.